Utility of genetic determinants of lipids and cardiovascular events in assessing risk.
about
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationMendelian randomization of blood lipids for coronary heart disease.Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.Wrapper-based selection of genetic features in genome-wide association studies through fast matrix operations.Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population.Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome.Acute coronary eventsMitochondrial DNA 5178 C/A polymorphism influences the effects of habitual smoking on the risk of dyslipidemia in middle-aged Japanese menFinding a place for genomics in health disparities research.Initiation of statin therapy: are there age limits?Comprehensive Analysis of Established Dyslipidemia-Associated Loci in the Diabetes Prevention Program.Genetic risk factors and Mendelian randomization in cardiovascular disease.Comparison of coronary heart disease genetic assessment with conventional cardiovascular risk assessment in primary care: reflections on a feasibility study.The impact of genomics on public health practice: the case for change.Decoding coronary artery disease: somatic mosaicism and genomics for personal and population risk prediction.
P2860
Q22306356-E20A4C15-F530-4704-8C73-46D2FAEE455AQ29547691-1DD92C73-5039-4BA5-81EC-4983D5278428Q30238784-1BEC2CA3-58C2-4206-8232-11564145B1B3Q30407506-EEAB2EF4-C41B-4E0C-8C9B-764F88A405D8Q30419436-313AA1AA-F292-4E36-8B84-8AAA8862317AQ34253599-F3C04CF3-3031-4B75-BAD7-0602B051446DQ35119321-3EE655FC-DBC6-42E5-8194-A41933F812FBQ35859582-96EF79B3-10D6-4687-BFF9-7E2D2D1BE2B0Q35878289-89DC6155-5425-414C-9D90-F38F745A2FC5Q36284130-FC368469-7545-4EED-98EC-6A9A1A08C291Q36936308-C0BAC32F-D9B6-4756-89A4-99EB522265A2Q37956537-6897A202-9729-4461-ABF6-8ED42C939AA3Q38385757-FF47CACF-F9F0-4B70-A4F1-FEA6B19E9DABQ38430758-99D3D48B-6B0A-49CF-A7DE-4F649F386B48Q39026617-FFE954A0-EECF-4B9A-B1D3-804FC302E134Q42287456-49EF895B-9C70-4189-B540-958C5A9AA460Q43419674-08A6271A-1E0F-47AD-8769-859EAB270B57
P2860
Utility of genetic determinants of lipids and cardiovascular events in assessing risk.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Utility of genetic determinants of lipids and cardiovascular events in assessing risk.
@en
Utility of genetic determinants of lipids and cardiovascular events in assessing risk.
@nl
type
label
Utility of genetic determinants of lipids and cardiovascular events in assessing risk.
@en
Utility of genetic determinants of lipids and cardiovascular events in assessing risk.
@nl
prefLabel
Utility of genetic determinants of lipids and cardiovascular events in assessing risk.
@en
Utility of genetic determinants of lipids and cardiovascular events in assessing risk.
@nl
P2860
P50
P356
P1476
Utility of genetic determinants of lipids and cardiovascular events in assessing risk.
@en
P2093
Michael V Holmes
Seamus Harrison
P2860
P304
P356
10.1038/NRCARDIO.2011.6
P407
P577
2011-02-15T00:00:00Z